The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).
 
Robert L. Ferris
Consulting or Advisory Role - Aduro Biotech; Amgen; AstraZeneca/MedImmune; Bain Capital Life Sciences; Bristol-Myers Squibb; EMD Serono; GlaxoSmithKline; Iovance Biotherapeutics; Lilly; Macrogenics; Merck; Nanobiotix; Numab; Oncorus; Ono Pharmaceutical; Pfizer; PPD; Regeneron; Tesaro; Torque; TTMS; TTMS
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Tesaro; TTMS; VentiRx
 
Yael Flamand
No Relationships to Disclose
 
Gregory S. Weinstein
Patents, Royalties, Other Intellectual Property - Olympus
 
Shuli Li
No Relationships to Disclose
 
Harry Quon
Employment - Epic (I); Johns Hopkins Hospital
Stock and Other Ownership Interests - Oncospace, Inc
Patents, Royalties, Other Intellectual Property - Johns Hopkins University School of Medicine
Other Relationship - Co-Founder, Pistevo Health
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Genentech
Research Funding - AstraZeneca; Merck
 
Joaquin J. Garcia
No Relationships to Disclose
 
Christine H. Chung
Consulting or Advisory Role - Bristol-Myers Squibb; CUE Biopharma; Ignyta; Mirati Therapeutics
Research Funding - AstraZeneca; Bristol-Myers Squibb; Ignyta; IRX Therapeutics; Lilly; Lion Biotechnologies; Merck; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca; Mirati Therapeutics
 
Maura L. Gillison
Consulting or Advisory Role - BioMimetix; Bristol-Myers Squibb; EMD Serono; Genocea Biosciences; Merck; Roche
Research Funding - Bristol-Myers Squibb (Inst); Genocea Biosciences (Inst)
 
Umamaheswar Duvvuri
No Relationships to Disclose
 
Bert W. O'malley
No Relationships to Disclose
 
Enver Ozer
No Relationships to Disclose
 
Giovana R. Thomas
No Relationships to Disclose
 
Wayne Koch
No Relationships to Disclose
 
Michael Elliot Kupferman
Stock and Other Ownership Interests - Abbvie; Intersect ENT
 
Richard Bryan Bell
Speakers' Bureau - Bristol-Myers Squibb; Merck; Regeneron
Research Funding - BMS; Merk
 
Nabil F. Saba
Honoraria - Aduro Biotech; Bristol-Myers Squibb; CUE Biopharma; Genentech/Roche; GlaxoSmithKline; Kura Oncology; Lilly; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Lilly; Merck; Pfizer
 
Miriam Lango
No Relationships to Disclose
 
Eduardo Mendez
No Relationships to Disclose
 
Barbara Burtness
Honoraria - AstraZeneca
Consulting or Advisory Role - Aduro Biotech; Alligator Bioscience; ALX Oncology; AstraZeneca; Bristol-Myers Squibb; Celgene; CUE Biopharma; Debiopharm Group; GlaxoSmithKline; Macrogenics; Maverick Therapeutics; Merck; Nanobiotix; Rakuten Medical
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Formation Biologics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Debiopharm Group; Merck